GGrantIndex
← Leaderboards

Richard K Albert

University Of Washington

$5,286,027
Attributed
$5,286,027
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200516
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$5,286,027 · 9

By mechanism

U10$4,091,822 · 1
N01$1,105,323 · 2
M01$88,882 · 6

Top collaborators

No co-investigators on record.

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Chronic Obstructive Airway Disease

Research focus

Chronic Obstructive Airway DiseaseOxygenHypoxemiaMortality Vital StatisticsUnited States National Institutes Of HealthAcuteChronicCostResourcesResearch PersonnelGrantTreatment TrialInstitutionFundingComputer Retrieval Of Information On Scientific Projects DatabaseQuality Of LifeSourceMacrolide AntibioticsAnti-Inflammatory AgentsDouble-Blind MethodAnti-Bacterial AgentsPlacebosOxygen Therapy CarePlacebo Control

Grant awards (17)

Long-term Oxygen Treatment Trial$11,563
N01 · FY2016 · HL · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) - REGIONAL CLINICAL CENTER$46,775
N01 · FY2015 · HL · contact PI
OPTION PERIOD II: 9/01/2013 - 12/31/2014, LOTT$97,816
N01 · FY2013 · HL · contact PI
Long-term Oxygen Treatment Trial$354,328
N01 · FY2012 · HL · contact PI
Long-term Oxygen Treatment Trial$370,290
N01 · FY2010 · HL · contact PI
CLINICAL TRIAL: EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS$6,407
M01 · FY2008 · RR · contact PI
EFFECT OF CHRONIC MACROLIDE ADMIN ON THE FREQNCY & SEVERTY OF COPD EXACERBATIONS$3,401
M01 · FY2008 · RR · contact PI
Novel Strategies Targeting Acute Exacerbation of COPD$982,969
U10 · FY2007 · HL · contact PI
EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS$41,404
M01 · FY2007 · RR · contact PI
EFFECT OF CHRONIC MACROLIDE ADMIN ON THE FREQNCY & SEVERTY OF COPD EXACERBATIONS$28,950
M01 · FY2007 · RR · contact PI
BENEFITS OF AMBULATORY OXYGEN IN HYPOXEMIC COPD PATIENTS$674
M01 · FY2007 · RR · contact PI
Novel Strategies Targeting Acute Exacerbation of COPD$798,959
U10 · FY2006 · HL · contact PI
BENEFITS OF AMBULATORY OXYGEN IN HYPOXEMIC COPD PATIENTS$8,046
M01 · FY2006 · RR · contact PI
Novel Strategies Targeting Acute Exacerbation of COPD$641,872
U10 · FY2005 · HL
Novel Strategies Targeting Acute Exacerbation of COPD$752,377
U10 · FY2004 · HL
Novel Strategies Targeting Acute Exacerbation of COPD$915,645
U10 · FY2003 · HL
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER$224,551
N01 · FY2000 · HR